Cybin (HELP) Cash & Equivalents (2020 - 2024)

Cybin (HELP) reported Cash & Equivalents of $149.6 million for Q4 2024, up 1124.53% on a YoY basis from $12.2 million in Q1 2024, and up 32.25% quarter-over-quarter from $113.1 million in Q3 2024.

Cybin (HELP) Cash & Equivalents (2020 - 2024) Analysis & Trends

Cybin has reported Cash & Equivalents for 5 years, with the latest figure at $149.6 million in Q4 2024.

  • For the quarter ending Q4 2024, Cash & Equivalents rose 1124.53% year-over-year to $149.6 million; the trailing twelve-month figure through Dec 2024 stood at $149.6 million (up 1124.53% YoY), and the FY2024 full-year result was $155.1 million, changed N/A from the prior year.
  • Cash & Equivalents for Q4 2024 stood at $149.6 million, up from $113.1 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $155.1 million in Q1 2024, with the low at $1.1 million in Q2 2020.
  • Historically, Cash & Equivalents has averaged $51.5 million across 5 years, with a median of $39.5 million in 2022.
  • Annual changes were most pronounced in 2021 — Cash & Equivalents jumped 4574.57% — and 2023, when it sank 69.83%.
  • Cybin's Cash & Equivalents stood at $3.0 million in 2020, then surged by 1910.21% to $59.6 million in 2021, then plunged by 33.74% to $39.5 million in 2022, then sank by 69.08% to $12.2 million in 2023, then surged by 1124.53% to $149.6 million in 2024.
  • The last three Cash & Equivalents figures came in at $149.6 million (Q4 2024), $113.1 million (Q3 2024), and $152.8 million (Q2 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 32.30 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 1.91 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 286.70 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 18.44 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 2.77 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 7.15 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 5.49 Bn
9 Abivax 91.96 Bn 91.96 Bn - 558.94 Mn
10 Cybin 75.42 Mn 75.42 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 149.61 Mn
Sep 30, 2024 113.12 Mn
Jun 30, 2024 152.80 Mn
Mar 31, 2024 155.10 Mn
Dec 31, 2023 12.22 Mn
Sep 30, 2023 12.41 Mn
Jun 30, 2023 12.38 Mn
Feb 28, 2023 30.15 Mn
Dec 31, 2022 39.52 Mn
Sep 30, 2022 41.13 Mn
May 31, 2022 31.99 Mn
Feb 28, 2022 4.54 Mn
Dec 31, 2021 59.64 Mn
Sep 30, 2021 50.86 Mn
Jun 30, 2021 52.09 Mn
Mar 31, 2021 50.59 Mn
Dec 31, 2020 2.97 Mn
Sep 30, 2020 5.78 Mn
Jun 30, 2020 1.11 Mn